Results overview: Found 4 records in 0.02 seconds.
Articles, 3 records found
Research literature, 1 records found
Articles 3 records found  
1.
5 p, 148.2 KB Diagnostic accuracy of salivary biomarkers for oral cancer and potentially malignant disorders : A systematic review protocol Precisión diagnóstica de biomarcadores salivales para cáncer oral y desórdenes potencialmente malignos: protocolo de revisión sistemática / Madera, Meisser (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Ariel Franco, J.V. (Instituto Universitario Hospital Italiano) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ; Arevalo-Rodriguez, Ingrid (Hospital Universitario Ramón y Cajal (Madrid)) ; Universitat Autònoma de Barcelona
Oral cancer has a 5-year survival rate of 50% because diagnosis is commonly performed at an advanced stage of the disease, so new diagnostic tools are needed. Nowadays, there is a vast number of publications suggesting the use of salivary biomarkers for oral cancer and potentially malignant disorders diagnosis, but their diagnostic accuracy is unclear. [...]
2020 - 10.5867/medwave.2020.05.7938
Medwave, Vol. 20 Núm. 5 (junio 2020) , p. e7938  
2.
12 p, 1.0 MB Frequency of anticancer drug use at the end of life : a scoping review / Szigethy, Endre (Epidy Kft (Ungria)) ; Dorantes, Rosario (Parc de Salut MAR de Barcelona) ; Sugrañes, Miguel (Universitat Autònoma de Barcelona) ; Madera, Meisser (University of Cartagena. Research Department, Faculty of Dentistry) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ; Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Anticancer drug use at the end of life places potential extra burdens on patients and the healthcare system. Previous articles show variability in methods and outcomes; thus, their results are not directly comparable. [...]
2023 - 10.1007/s12094-023-03234-1
Clinical & Translational Oncology, june 2023, p. 1-12  
3.
14 p, 2.3 MB Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer / Madera Anaya, Meisser Vidal (Institut d'Investigació Biomèdica Sant Pau) ; Franco, Juan Victor Ariel (Hospital Italiano de Buenos Aires (Argentina)) ; Ballesteros Silva, Mónica Patricia (Institut d'Investigació Biomèdica Sant Pau) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ; Bonfill, X. (Xavier) (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ; Universitat Autònoma de Barcelona
This evidence mapping aims to describe and assess the quality of available evidence in systematic reviews (SRs) on treatments for oral cancer. We followed the methodology of Global Evidence Mapping. [...]
2018 - 10.2147/CMAR.S186700
Cancer Management and Research, Vol. 11 (december 2018) , p. 117-130  

Research literature 1 records found  
1.
149 p, 7.3 MB Quality assessment of scientific evidence about diagnosis and treatments for oral cancer / Madera, Meisser ; Bonfill, X. (Xavier), dir. ; Urrútia, Gerard, dir.
El càncer oral és considerat, globalment, un problema de salut pública. Aquest té una taxa de supervivència al cap de 5 anys del 50%, ja que el seu diagnòstic es realitza, en general, en estadis avançats. [...]
El cáncer oral es considerado un problema de salud pública globalmente. Este tiene una tasa de supervivencia a los 5 años del 50%, debido a que su diagnóstico se realiza comúnmente en estadios avanzados. [...]
Oral cancer is considered a public health problem worldwide. It has a 5-year survival rate of 50% due to diagnosis are commonly performed at advanced stage of the disease. Its treatment usually involves a multidisciplinary team to provide comprehensive healthcare to people that suffer from this disease. [...]

2020  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.